Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ADMA Biologics Inc (ADMA : NSDQ)

• Company Description    ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey. Number of Employees: 527

• Price / Volume Information    Yesterday's Closing Price: $2.05 Daily Weekly Monthly 20 Day Moving Average: 2,981,909 shares Shares Outstanding: 195.92 (millions) Market Capitalization: $401.64 (millions) Beta: 1.07 52 Week High: $2.16 52 Week Low: $1.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.99% 14.88% 12 Week 30.57% 43.56% Year To Date 45.39% 77.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 465 STATE ROUTE 17 - RAMSEY,NJ 07446 USA ph: 201-478-5552 fax: 201-478-5553 info@admabio.com http://www.admabiologics.com

• General Corporate Information    Officers Adam S. Grossman - President and Chief Executive Officer Steven A. Elms - Chairman Jerrold B. Grossman - Vice Chairman Brian Lenz - Executive Vice President and Chief Financial Offic Martha J. Demski - Director Peer Information ADMA Biologics Inc (CORR.) ADMA Biologics Inc (RSPI) ADMA Biologics Inc (CGXP) ADMA Biologics Inc (BGEN) ADMA Biologics Inc (GTBP) ADMA Biologics Inc (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 000899104 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 195.92 Most Recent Split Date: (:1) Beta: 1.07 Market Capitalization: $401.64 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.31 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.16 Price/Cash Flow: - Price / Sales: 4.27 EPS Growth vs. Year Ago Period: 37.50% vs. Previous Quarter: -11.11% Sales Growth vs. Year Ago Period: 81.34% vs. Previous Quarter: 10.31% ROE 03/31/22 - -59.36 12/31/21 - -61.23 09/30/21 - -71.69 ROA 03/31/22 - -27.13 12/31/21 - -29.14 09/30/21 - -32.53 Current Ratio 03/31/22 - 7.60 12/31/21 - 6.87 09/30/21 - 5.41 Quick Ratio 03/31/22 - 3.19 12/31/21 - 2.77 09/30/21 - 1.88 Operating Margin 03/31/22 - -76.18 12/31/21 - -88.51 09/30/21 - -108.60 Net Margin 03/31/22 - -83.27 12/31/21 - -88.51 09/30/21 - -108.60 Pre-Tax Margin 03/31/22 - -83.27 12/31/21 - -88.52 09/30/21 - -108.60 Book Value 03/31/22 - 0.65 12/31/21 - 0.72 09/30/21 - 0.74 Inventory Turnover 03/31/22 - 0.73 12/31/21 - 0.74 09/30/21 - 0.78 Debt-to-Equity 03/31/22 - 1.15 12/31/21 - 0.72 09/30/21 - 0.99 Debt-to-Capital 03/31/22 - 53.44 12/31/21 - 42.02 09/30/21 - 49.63

Powered by Zacks Investment Research ©